Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions
Open Access
- 29 January 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 79 (5-6) , 759-763
- https://doi.org/10.1038/sj.bjc.6690122
Abstract
Reduced expression of BRCA1 has been implicated in sporadic breast cancer, although the mechanisms underlying this phenomenon remain unclear. To determine whether regulatory mutations could account for the reduced expression, we screened the promoter region by sequencing in 20 patients with sporadic disease. No mutations were detected; however, a new polymorphism consisting of a C-to-G base change within the β-promoter was identified, with the frequency of the G allele being 0.34. Close to complete linkage disequilibrium was found between this marker and the Pro871Leu polymorphism, situated in exon 11, which has previously been shown not to be associated with breast or ovarian cancer. This indicates that the C/G polymorphism is also unlikely to play a role in either disease. However, the strength of linkage disequilibrium between these markers permitted their use for rapid screening for genomic deletions within BRCA1. A series of 214 cases with familial breast cancer were analysed using this approach; 88/214 were heterozygous for the promoter polymorphism, thereby excluding a deletion in this region. Among the remaining patients, one hemizygous case reflecting a promoter deletion was successfully identified. Therefore, this study indicates that deletions within the β-promoter region of BRCA1 are an uncommon event in familial breast cancer. Furthermore, it suggests that mutations within the BRCA1 promoter are unlikely to account for the reported decreased expression of BRCA1 in sporadic disease.Keywords
This publication has 23 references indexed in Scilit:
- Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristicsOncogene, 1999
- CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding siteOncogene, 1998
- BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patientsNature Genetics, 1997
- Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer familyHuman Molecular Genetics, 1997
- Mutations of theBRCA1gene in human cancerSeminars in Cancer Biology, 1996
- Mutations and Polymorphisms in the familial early-onset breast cancer (BRCA1) geneHuman Mutation, 1996
- Distinct transcription start sites generate two forms of BRCA1 mRNAHuman Molecular Genetics, 1995
- The Association of Polymorphic N‐Acetyltransferase (NAT2) with Breast Cancer RiskAnnals of the New York Academy of Sciences, 1995
- A somatic BRCA1 mutation in an ovarian tumourNature Genetics, 1995
- BRCA1 Mutations in Primary Breast and Ovarian CarcinomasScience, 1994